New research suggests that people who take statins may be less likely to die from COVID-19, the Guardian newspaper reported on Thursday.
A large study published in PLOS Medicine looked at the relationship between the cholesterol-lowering drugs and COVID-19 related mortality.
The results indicate that statins are associated with a slightly lower risk of dying from COVID-19, although experts stressed that the findings did not prove that the drugs can reduce death rates.
Randomised studies would be needed to ascertain whether there is a causal relationship, the researchers said.
TiumBio files Clinical Trial Application to start Phase 1b TU7710 study
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval